Lipo Lab South Africa
Cagrisema 12mg Injectable Weight Loss Pen South Africa – Body Pharm
Cagrisema 12mg Injectable Weight Loss Pen South Africa – Body Pharm
Couldn't load pickup availability
Cagrisema 12mg Injectable Weight Loss Pen South Africa – Body Pharm
Cagrisema 12mg Injectable Weight Loss Pen from Body Pharm is a powerful, once‑weekly dual‑agonist therapy designed to support significant weight reduction, appetite control and improved metabolic health. Ready to buy online in South Africa? Shop now and take the next step toward sustainable weight management under professional supervision.
How Cagrisema 12mg Works – Cagrisema South Africa
Cagrisema combines two complementary hormone‑based agents in a pre‑filled, easy‑to‑use pen to reduce hunger and support better glycaemic control. The dual action helps slow gastric emptying, increase satiety and reduce caloric intake — making it suitable for adults in South Africa seeking clinically backed weight‑loss support when used with diet and exercise and under medical guidance.
Key Benefits of Cagrisema 12mg Pen
- Dual mechanism: Semaglutide + Cagrilintide for enhanced appetite suppression.
- Once‑weekly dosing: Convenient pre‑filled pen for simple adherence.
- Clinically meaningful weight loss: Trials show substantial reductions in body weight when used appropriately.
- Improves metabolic markers: Supports blood sugar control and insulin balance.
- Suitable for South African buyers: Nationwide delivery and local customer support.
Active Ingredient Profile (Dual-Agonist)
Cagrisema 12mg combines two distinct hormone-based therapies in a single injection to maximize metabolic efficacy.
1. Semaglutide (6mg)
GLP-1 Receptor AgonistFunction: Mimics the GLP-1 hormone released by the gut after eating.
Benefit: It targets the brain's appetite centres to reduce hunger and cravings while improving insulin secretion and blood sugar management.
2. Cagrilintide (6mg)
Long-Acting Amylin AnalogueFunction: Mimics the hormone Amylin, which is co-secreted with insulin.
Benefit: It physically slows down gastric emptying (how fast food leaves your stomach), leading to a prolonged feeling of fullness (satiety) after smaller meals.
💡 Why the Combination? (The Synergistic Effect)
Clinical investigation suggests that targeting both the GLP-1 and Amylin pathways simultaneously yields superior weight loss results compared to using Semaglutide alone. The dual-action approach attacks weight gain from two physiological angles: appetite suppression and physical satiety.
Recommended Dosage Schedule
Important: This schedule is a guideline based on the standard Body Pharm protocol. Always follow professional medical advice. Do not start at the maximum dose.
| Phase | Week | Dosage | Pen Setting |
|---|---|---|---|
| Starting | Weeks 1–4 | 0.25 mg | Select 0.25 |
| Step Up 1 | Weeks 5–8 | 0.50 mg | Select 0.50 |
| Step Up 2 | Weeks 9–12 | 1.00 mg | Select 1.0 |
| Maintenance | Week 13+ | 2.00 mg* | Select 2.0 |
*Custom Dosing Note: The Body Pharm pen allows for micro-dosing. If you experience side effects when jumping from 0.5mg to 1.0mg, you may use the 0.75mg setting for 2–4 weeks to ease the transition.
Storage & Handling Instructions
❄️ Before Opening
Store in a refrigerator between 2°C to 8°C. Keep the pen in the original carton to protect it from light. Ensure it is not placed directly against the cooling element or back wall of the fridge.
📅 After Opening (In Use)
Once opened, the pen can be stored in the refrigerator (2°C to 8°C) for up to 8 weeks. Always replace the pen cap after each injection to protect the solution from light.
⚠️ CRITICAL WARNING - DO NOT FREEZE:
If the solution freezes, the active peptides (Semaglutide & Cagrilintide) will be destroyed. Do not use the pen if it has been frozen, even if it has thawed. Inspect the solution before use; it should be clear and colourless.
Quick Product Snapshot
| Feature | Details |
|---|---|
| Size | 12 mg total (6 mg Semaglutide + 6 mg Cagrilintide) pre‑filled pen |
| Format | Pre‑filled, dose‑selectable injectable pen — subcutaneous use |
| Usage | Adult weight management under medical supervision; once‑weekly injection |
| Active Ingredients | 6 mg Semaglutide + 6 mg Cagrilintide per pen |
| Origin | Body Pharm – imported and supplied to customers in South Africa |
| Shipping | Nationwide delivery in South Africa within 5–6 business days (tracked, discreet) |
How to Use Cagrisema 12mg Pen — Step‑by‑Step
- Consult a healthcare professional: Confirm suitability, contraindications and dosing plan.
- Prepare the pen: Check the pen for damage, remove cap and inspect solution (clear, colourless).
- Select dose: Set the dose selector to the prescribed weekly dose.
- Choose injection site: Use abdomen, thigh or upper arm (rotate sites each week).
- Clean skin: Wipe with an alcohol swab and allow to dry.
- Inject: Insert the needle subcutaneously and press the button to deliver the dose; hold for 5–10 seconds.
- Dispose safely: Use a sharps container for needles and follow local medical waste guidelines.
- Monitor: Track appetite, side effects and weight; report concerns to your healthcare provider promptly.
Ingredient Breakdown
| Ingredient | Benefit |
|---|---|
| Semaglutide (6 mg) | GLP‑1 receptor agonist that slows gastric emptying, reduces post‑meal blood sugar spikes and lowers appetite and cravings. |
| Cagrilintide (6 mg) | Amylin analogue that increases feelings of fullness, reduces caloric intake and complements GLP‑1 effects for enhanced weight loss. |
| Sterile vehicle / excipients | Supports stability and delivery of active ingredients (sterile aqueous formulation). See your prescriber for full formulation details. |
Safety & Important Information — South Africa
Important: Cagrisema is under global clinical investigation and should be used only under the supervision of a qualified healthcare professional. Not suitable for pregnant or breastfeeding women. Discuss your medical history, current medications and allergies with your prescriber. Monitor for common side effects (nausea, GI disturbances) and seek medical advice for severe or persistent reactions.
Frequently Asked Questions (FAQ)
Is Cagrisema available for purchase in South Africa?
Yes — we supply Cagrisema 12mg pens to customers across South Africa with tracked, discreet shipping. A valid prescription or medical recommendation is required, and use should be supervised by a healthcare professional.
How quickly will I see results?
Individual responses vary. Many users notice reduced appetite and early weight changes within a few weeks, with more significant weight loss over months when combined with lifestyle changes and the recommended dosing schedule.
Can I combine Cagrisema with other medications or GLP‑1 products?
Combining medications can increase risks. Only combine therapies under direct medical supervision. Your healthcare provider can advise whether additional agents are appropriate for your treatment plan.
What is your shipping and returns policy?
We deliver nationwide within 5–6 business days. Due to the medical nature of this product, returns and exchanges cannot be accepted. If you receive a damaged or incorrect item, contact us immediately for assistance.
Real Reviews — South African Customers
- "Finally a weekly option that I can stick to. I’ve seen steady progress over three months." — L. Naidoo, Durban
- "Discreet delivery and helpful support. My appetite is much better controlled." — M. van der Merwe, Cape Town
- "Easy to use pen and clear dosing. Worth trying under my doctor’s care." — S. Patel, Johannesburg
- "Good customer service and reliable shipping within SA. Noticeable results when combined with diet changes." — T. Mbatha, Pretoria
Why Buy From Us / Guarantee
- Authenticity guaranteed: We source Cagrisema from trusted manufacturers and verify product integrity.
- Local support: Customer service based in South Africa to assist with ordering and shipping queries.
- Discreet, tracked delivery: Sensitive packaging and reliable courier service nationwide.
- Medical guidance: We encourage and support use under qualified healthcare supervision for safe, effective outcomes.
Disclaimer: For research and personal use only under professional supervision. Not an officially registered treatment in all jurisdictions. Consult your healthcare professional before use.
Share
